GL1X · GenesisL1 explorer

Research workbench

Crystal structure analysis of the MMP13 catalytic domain in complex with specific inhibitor

Analyse Crystal structure analysis of the MMP13 catalytic domain in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2OW9
Type
protein
Length
333 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Collagenase 3
EC
3.4.24.-
UniProt
P45452
Ligands
SP6, HAE, CA, ZN, SO4
Pockets
2 · best druggability 0.73

Structure

x-ray diffraction · 2 distinct chains · 24% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACollagenase 3 (EC 3.4.24.-)protein16724% helix, 19% strandP45452
BCollagenase 3 (EC 3.4.24.-)protein16623% helix, 19% strandP45452

Ligands and binding sites

  • SP6 · Benzyl 6-benzyl-5,7-dioxo-6,7-dihydro-5H-[1,3]thiazolo[3,2-c]pyrimidine-2-carboxylate · ligand · 2 copies · chains A, B
  • HAE · Acetohydroxamic acid · ligand · 2 copies · chains A, B
  • CA · Calcium ion · metal · 7 copies · chains A, B
  • ZN · Zinc ion · metal · 4 copies · chains A, B
  • SO4 · Sulfate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17190.730.7975ZN, SP6, HAE
22520.630.8143SP6, HAE

Interfaces

1 interface between chains.

  • A–B · 1224 Ų buried · 15 hydrogen bonds · protein-protein

Compared structures

  • 2OW9 · Crystal structure analysis of the MMP13 catalytic domain in complex with specific… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.